University · founded 1789
University of North Carolina at Chapel Hill
Chapel Hill, United States · unc.edu
- Citations, last 5 years
- 571.2k
- Works, last 5 years
- 93.1k
- h-index
- 1,675
- Scientists listed
- 9 724
- Grants since 2016
- 10.8k
Grants received
2022–2027 · research · R01
Sitting Interruption and Whole-body Cardiovascular Health: Linking Physiological Responses to Risk Behaviors
Erik D Hanson · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · research · R25
Transforming Kidney Care through Skill and Workforce Development: the North Carolina Kidney Technology Incubator (NC-KTI)
Theo Dingemans · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2026 · research · R01
Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic
Bo Li · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · fellowship · F30
Identifying the role of manganese limitation in antibiotic killing of Staphylococcus aureus
Amanda Zoyla Velez · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · research · R01
Digital health platform (DHP) to deliver Mindfulness as a Stress Management Intervention Leveraging Electronic (SMILE) health records for racial and ethnic populations during the COVID-19 pandemic
Maria I Davila · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Integrating tumor and stroma to understand and predict treatment response
Naim Ur Rashid · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · career development · K24
Mentoring in Patient Oriented Research in Osteoarthritis
Amanda E Nelson · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · career development · K23
Biopsychosocial Risk Factors for Psychiatric Disorders Following Kidney Transplantation
Rebekah Potts Nash · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · research · R01
Modulation of VSMC phenotype through the Insulin Receptor Substrate-1/Kruppel-like factor-4 signal transduction pathway: a Novel Target for AVF Dysfunction
Prabir Roy-Chaudhury · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Core C: Imaging Core
Camille Ehre · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder
Kevin Peter Williams · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
The Reciprocal Relationship between Binge Drinking and Astrocytic Signaling
Simon Alexander Marshall · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Fulton T Crews · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Development of Antivirals against Filovirus Replication
Ralph S Baric · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Development of direct-acting flavivirus inhibitors
Ralph S Baric · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 4: Biophysical and structural characterization of airway submucosal gland mucus in health and disease
Ronit Freeman · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Core A: Administrative/Biostatistics Core
Richard Charles Boucher · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Developing Broad-Spectrum Antivirals Targeting Coronavirus Replicase and Helicase
Timothy Patrick Sheahan · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 3: Membrane-bound mucins on the airway surface ensure efficient mucus clearance and lung health
Brian M Button · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Core B: Discovery Core
Kenneth Hugh Pearce · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Core C: Enzymology Core
Craig E. Cameron · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
SToP Cancer SPORE: Career Enhancement Program
Jonathan S. Serody · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2023 · program · P30
Pilot and Feasibility Program
Steven H Zeisel · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
Project 2: Combined CAR-T cell therapy
Gianpietro Dotti · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
Core C - Integrated Quantitative Science (IQS)
Michael R Kosorok · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Alcohol-Associated Toxicity and Genomic Instability of Mammary Stem Cells
Xiaohe Yang · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2025 · cooperative agreement · U19
Research Project 1: Coronavirus antiviral lead development and combination testing
Ralph S Baric · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
Project 3: Transcriptomic subtypes, therapy selection and response
Jen Jen Yeh · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
Richard Charles Boucher · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Core C: Imaging Core
Camille Ehre · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Core B: Mucus/Mucin Analytics Core
Mehmet Kesimer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder
Kevin Peter Williams · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
The Reciprocal Relationship between Binge Drinking and Astrocytic Signaling
Simon Alexander Marshall · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 4: Biophysical and structural characterization of airway submucosal gland mucus in health and disease
Ronit Freeman · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
SToP Cancer SPORE: Career Enhancement Program
Jonathan S. Serody · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P50
Core B - Tissue Procurement, Pathology, and Genomics
Alina Iuga · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 1: Mucin structure and associations in respiratory mucus
David Hill · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Alcohol-Associated Toxicity and Genomic Instability of Mammary Stem Cells
Xiaohe Yang · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · program · P01
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
Richard Charles Boucher · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Scientific Mentoring and Research Experiences Core
Leon Garland Coleman · University of North Carolina at Chapel Hill · funded by National Institutes of Health
